Search results
Results from the WOW.Com Content Network
Hedge fund manager Bridgewater Associates said Chinese startup DeepSeek's launch of its latest artificial intelligence (AI) models could lead to a short-term correction in many tech companies ...
Nano Today is dedicated to publishing the most influential and innovative work across nanoscience and technology. The journal considers any article that informs readers of the latest research and advances in the field, research breakthroughs, and topical issues which express views on developments in related fields.
Naqaa Nanotechnology Network NNN, an affiliate of Naqaa foundation for Scientific Research, Technology and Development; NanoTech Egypt [3] Egypt Nanotechnology Center; Center for Nanotechnology (CNT) at Nile University [4] NBE Institute for Nanoscience and Informatics (INI) at Zewail City of Science and Technology
Log9 Materials is an Indian nanotechnology company, headquartered in Bangalore, [2] operating in the areas of sustainable energy and filtration.With 16 patents around Graphene, Log9 Materials has developed Aluminium–air battery, aluminium fuel cells for both mobility and stationary energy applications.
Super Micro Computer (NASDAQ: SMCI) stock got hit hard with sell-offs in Monday's trading. The server specialist's share price ended the day down 12.5% amid a 1.8% decline for the S&P 500 index ...
Trump said that he still expected U.S. tech companies to dominate artificial intelligence, but he acknowledged the challenge posed by DeepSeek, a low-cost AI assistant that rose to No. 1 on the ...
Nanosys Quantum Dot Enhancement Film, or QDEF, is an optical film component for LED driven LCDs. Each sheet of QDEF contains trillions of tiny Quantum Dot Phosphors.QDEF enables LED-backlit LCDs to be brighter and more colorful by providing a high quality, tri-color white light from a standard blue LED light source.
Acuitas Therapeutics Inc. is a Canadian biotechnology company based in Vancouver, British Columbia.The company was established in February 2009 to specialize in the development of delivery systems for nucleic acid therapeutics based on lipid nanoparticle (LNP) technology, a key component of the mRNA vaccines deployed for COVID-19.